What does this video actually claim?
@_priss97 presents her "injection day" as her favorite day of the week, promoting tirzepatide (Zepbound) through telehealth platform Amble. She frames the weekly injection routine as something to celebrate.
The video doesn't make explicit medical claims but positions tirzepatide injections as a positive lifestyle choice. Her enthusiastic framing and hashtags like #glp1forweightloss suggest this is part of a weight management journey she's documenting for her audience.
The promotional nature is clear from her partnership with Amble, though she does properly disclose this relationship in her content.
Is tirzepatide actually effective for weight loss?
Yes, the clinical data for tirzepatide is genuinely impressive. The SURMOUNT-1 trial (Jastreboff et al., NEJM, 2022) showed 22.5% body weight reduction with the 15mg dose over 72 weeks.
That's substantially higher than what we see with semaglutide. The same trial found 15% weight loss with the 10mg dose and 20% with 15mg. About 40% of participants lost at least 25% of their body weight on the highest dose.
The FDA approved tirzepatide as Zepbound for weight management in November 2023, specifically for adults with obesity or overweight with weight-related health problems. So @_priss97 isn't wrong about the drug's potential.
What's problematic about this presentation?
Celebrating "injection day" as a favorite day glosses over real side effects many people experience. The SURMOUNT trials reported nausea in 67% of participants and vomiting in 30%.
Her upbeat framing might set unrealistic expectations for viewers considering tirzepatide. Most people don't love injection days, especially during the initial titration period when GI side effects peak.
The lifestyle influencer approach to prescription medications also raises questions. While she's transparent about her partnership, turning medical treatment into content can blur important boundaries between healthcare and social media marketing.
How does telehealth prescribing actually work?
Platforms like Amble can legally prescribe tirzepatide for weight management, but the process should involve proper medical screening. FDA guidelines require BMI of 30 or higher, or 27 with weight-related conditions.
Legitimate telehealth providers conduct medical histories, review contraindications, and provide ongoing monitoring. The starting dose is typically 2.5mg weekly, increasing gradually to minimize side effects.
However, the influencer marketing model does create pressure to make the process seem easier than it often is. Real medical care isn't always Instagram-worthy, and that's actually fine.
What should you know about tirzepatide costs and access?
Zepbound's list price is around $1,060 monthly without insurance. Many insurance plans don't cover it for weight loss, making telehealth platforms attractive for patients seeking access.
Some telehealth companies offer compounded versions at lower costs, though FDA guidance on compounding has been inconsistent. The supply shortages that plagued semaglutide are also affecting tirzepatide availability.
@_priss97's positive experience doesn't reflect the financial reality most people face. The celebratory tone might feel different when you're paying over $12,000 yearly out of pocket.